To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT06158750

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
  • Phenox GmbH Registry lists this organization as a collaborator
Registry
  • NCT NCT06158750
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06158750. Allocation not applicable; no masking; primary purpose treatment. Start 2023-11-17 (actual); primary completion 2026-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
Condition
Intracranial Aneurysm
Intervention (Device)
p64/p48 MW HPC Flow Modulation Device
Lead sponsor
Shanghai Wallaby Medical Technologies Co.,Inc. (class: industry)
Collaborator
Phenox GmbH (class: industry)
Collaborator
Beijing Wallaby Medical Technologies Co.,Inc. (class: not stated)

Record details

Record id
cardio:ct-nct06158750
Content hash
761b5a35dff384bf16f46267b8e5bb1237aeff3bb6573cd6ff387d41bb974c6f